Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic (Q74450077)
Jump to navigation
Jump to search
scientific article published on 01 April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic |
scientific article published on 01 April 1998 |
Statements
Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis (English)
Wühl E
Haffner D
Gretz N
Offner G
van't Hoff WG
Broyer M
1 April 1998